Revolutionizing MedTech for a Better Tomorrow
BioXcyte
At BioXcyte, we are transforming the landscape of healthcare diagnostics through cutting-edge point-of-care solutions. Our mission is to empower clinicians and patients with rapid, accurate, and accessible diagnostic tools that bridge the gap between early detection and timely intervention.
WHO WE ARE: A Singapore-MIT spin-off led by scientists, engineers and clinicians in the field of microfluidics, clinical immunology, and AI diagnostics.
The Problem
Our immune cells responds and guards against various health threats such as infection, cancer and chronic diseases. Yet, there is a lack of rapid bedside test for immune cell response to guide clinical diagnosis and therapy.
Our Solution
A rapid bedside test for immune cells at point-of-care with a drop of blood is a game changer.